FindTrial
Sign In

COMPARITIVE STUDY BETWEEN DEXMEDETOMEDINE AND BUPRENORPHINE AS AN ADJUVANT TO ROPIVACAINE 0.5% IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB ORTHOPEDIC SURGERIES

A PROSPECTIVE RANDOMIZED, COMPARITIVE STUDY BETWEEN DEXMEDETOMEDINE AND BUPRENORPHINE AS AN ADJUVANT TO ROPIVACAINE 0.5% IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB ORTHOPEDIC SURGERIES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037274
Enrollment
90
Registered
2021-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S521- Fracture of upper end of radius Health Condition 2: S520- Fracture of upper end of ulna

Interventions

Control Intervention1: buprenorphine: buprenorphine 3mcg/kg at the time of block administration Control Intervention2: dexmedetomidine: dexmedetomidine 1mcg/kg at the time of block administration

Sponsors

Sanjay Gandhi Institute Of Trauma And Orthopedics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 18 to 60 years admitted for elective upperlimb orthopaedic surgeries in Sanjay Gandhi Institute Of Trauma And Orthopaedics,Bengaluru

Exclusion criteria

Exclusion criteria: History of neurological, psychiatric, neuromuscular,alcoholism or drug abuse and patients receiving adrenoceptor agonist or antagonist therapy.

Design outcomes

Primary

MeasureTime frame
time of onset of sensory block and duration of analgesiaTimepoint: 1 day—

Secondary

MeasureTime frame
any adverse effectsTimepoint: 1 day—

Countries

India

Contacts

Public ContactDr Sangeetha C

Sanjay Gandhi Institute of Trauma And Orthopedics

sangudaya.sd@gmail.com9886623479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026